David Bharucha
Chief Tech/Sci/R&D Officer at MILESTONE PHARMACEUTICALS INC.
Net worth: 23 890 $ as of 2024-04-29
Profile
David B.
Bharucha is currently the Chief Medical Officer at Milestone Pharmaceuticals, Inc. Prior to this, he worked as the VP-Clinical Development, Research & Development at Allergan Ltd.
(Ireland) from 2018 to 2021.
Dr. Bharucha received his undergraduate degree from Haverford College and his doctorate degree from The University of Chicago.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-14 | 15,120 ( 0.03% ) | 23 890 $ | 2024-04-29 |
David Bharucha active positions
| Companies | Position | Start |
|---|---|---|
| MILESTONE PHARMACEUTICALS INC. | Chief Tech/Sci/R&D Officer | 2022-02-14 |
Former positions of David Bharucha
| Companies | Position | End |
|---|---|---|
| ALLERGAN PLC | Corporate Officer/Principal | 2020-12-31 |
Training of David Bharucha
| The University of Chicago | Doctorate Degree |
| Haverford College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- David Bharucha
